Email us for help
Loading...
Premium support
Log Out
Our Terms of Use and Privacy Policy have changed. We think you'll like them better this way.
To be added to the distribution list, please email: DDeCastro@southlakeregional.org
In this episode of the Medoncnow, Dr. Adrian Sacher joins us again and will help us understand how to incorporate Tarlatamab into our management strategy for Extensive Stage Small Cell Lung cancer.
Key Opinion Leader:
Dr. Adrian Sacher Assistant Professor of Medicine and Immunology Staff Medical Oncologist and Affiliate Scientist Princess Margaret Cancer Centre University of Toronto
Host: Shaqil Kassam MD. MSc. FRCPC skassam@southlakeregional.org Medical Oncologist Stronach Regional Cancer Centre, Newmarket, Ontario
Previous episodes: https://www.blogtalkradio.com/medoncnow
X - @medoncnow
